|
Market Closed -
Nasdaq
01:30:00 31/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 32.12 USD | +0.38% |
|
-5.78% | -23.52% |
| 30/10 | US FDA issues warning on Medline beds after 2 deaths, 16 serious injuries | RE |
| 30/10 | US FDA issues warning on Medline beds after 2 deaths, 16 serious injuries | RE |
| Market Cap | 2.82TCr 2.52TCr 2.32TCr 2.1TCr 3.93TCr 2,67600Cr 4.01TCr 28TCr 11TCr 1,40800Cr 11TCr 10TCr 4,43900Cr | P/E 2026 * |
43.5x | P/E 2027 * | 28.4x |
|---|---|---|---|---|---|
| Enterprise Value | 3.81TCr 3.41TCr 3.14TCr 2.85TCr 5.32TCr 3,61900Cr 5.42TCr 37TCr 15TCr 1,90400Cr 14TCr 14TCr 6,00400Cr | EV / Sales 2026 * |
1.22x | EV / Sales 2027 * | 1.09x |
| Free-Float |
66.56% | Yield 2026 * |
0.23% | Yield 2027 * | 0.3% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| MDLN | Delayed | |
CBOE
| MDLN | Real-time | |
|
BOERSE DUESSELDORF
| L10 | End-of-day quote | |
|
Xetra
| L10 | Delayed | |
|
Deutsche Boerse AG
| L10 | Delayed | |
|
Tradegate
| L10 | Real-time | |
|
Boerse Muenchen
| L10 | Real-time |
Last Transcript: Medline Inc.
| 1 day | +0.38% | ||
| 1 week | -5.78% | ||
| Current month | -7.44% | ||
| 1 month | -7.44% | ||
| 3 months | -17.89% | ||
| 6 months | -27.77% | ||
| Current year | -23.52% |
| 1 week | 31.37 |  | 34.25 |
| 1 month | 31.37 | | 37.02 |
| Current year | 31.37 | | 50.88 |
| 1 year | 31.37 | | 50.88 |
| 3 years | 31.37 | | 50.88 |
| 5 years | 31.37 | | 50.88 |
| 10 years | 31.37 | | 50.88 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 08/10/26 | GIC Pte Ltd. (Investment Management)
| Sell | Company | -78,16,987 | 0.8910% | |
| 06/10/26 | GIC Pte Ltd. (Investment Management)
| Sell | Company | -92,72,000 | 1.0568% | |
| 19/08/26 | Free | Chief Operating Officer | 87,667 | 0.0119% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.38% | -5.78% | - | - | 2.82TCr | |
| +1.56% | +2.41% | -14.82% | +14.19% | 18TCr | |
| -6.38% | -4.98% | -20.90% | +11.15% | 11TCr | |
| -0.59% | +1.18% | +6.12% | +37.97% | 12TCr | |
| +3.42% | +1.71% | -42.32% | +9.52% | 9.46TCr | |
| +0.09% | -0.05% | -3.04% | +78.44% | 6.31TCr | |
| -0.46% | +0.42% | +8.19% | +82.97% | 5.57TCr | |
| -0.23% | -0.52% | +10.31% | -21.19% | 5.39TCr | |
| -4.30% | -1.64% | -12.30% | +39.06% | 4.34TCr | |
| +0.58% | +2.00% | -1.07% | -6.43% | 3.47TCr | |
| Average | -0.59% | -0.53% | -7.76% | +27.30% | 7.87TCr | |
| Weighted average by Cap. | -0.46% | +0.02% | -10.66% | +25.22% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.12TCr 2.8TCr 2.57TCr 2.33TCr 4.36TCr 2,96500Cr 4.44TCr 31TCr 12TCr 1,56000Cr 12TCr 11TCr 4,91900Cr | 3.37TCr 3.02TCr 2.77TCr 2.51TCr 4.7TCr 3,19800Cr 4.79TCr 33TCr 13TCr 1,68200Cr 13TCr 12TCr 5,30500Cr |
| Net income | 94Cr 84Cr 77Cr 70Cr 130.72Cr 8.9TCr 133.17Cr 920.42Cr 369.49Cr 4.68TCr 351.61Cr 344.13Cr 15TCr | 153.49Cr 137.46Cr 126.44Cr 114.57Cr 214.16Cr 15TCr 218.17Cr 1.51TCr 605.3Cr 7.67TCr 576.02Cr 563.77Cr 24TCr |
| Net Debt | 993.57Cr 889.84Cr 818.52Cr 741.64Cr 1.39TCr 94TCr 1.41TCr 9.76TCr 3.92TCr 50TCr 3.73TCr 3.65TCr 1,56500Cr | 850.08Cr 761.33Cr 700.3Cr 634.53Cr 1.19TCr 81TCr 1.21TCr 8.35TCr 3.35TCr 42TCr 3.19TCr 3.12TCr 1,33900Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/26/30 | $32.12 | +0.37% | 1,45,73,303 |
| 29/26/29 | $32.00 | -1.14% | 1,58,90,551 |
| 28/26/28 | $32.37 | -0.03% | 85,15,390 |
| 27/26/27 | $32.38 | -3.89% | 1,06,54,943 |
| 26/26/26 | $33.69 | -1.17% | 81,32,393 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MDLN Stock
Select your edition
All financial news and data tailored to specific country editions
